Cefotaxime-hydrolysing beta lactamases in Morganella morganii

Eur J Clin Microbiol Infect Dis. 1999 Oct;18(10):743-7. doi: 10.1007/s100960050391.

Abstract

The frequency of enterobacterial isolates with high resistance to expanded-spectrum beta-lactam antibiotics (mainly cefotaxime or ceftriaxone) has increased notoriously in Argentina, mainly because of the spread of extended-spectrum beta-lactamases. The aim of this work was the study of extended-spectrum beta-lactamases in several Morganella morganii isolates with unusually high resistance to ceftriaxone. These strains produced at least two beta-lactamases, of apparent pIs of 5.4 and 8.2, molecular weight 23 000, well inhibited by clavulanate, compatible with a broad-spectrum beta-lactamase - perhaps TEM-1 - and an extended-spectrum beta-lactamase, respectively. The extended-spectrum beta-lactamase was identified as a CTX-M-type beta-lactamase - probably CTX-M-2 - by polymerase chain reaction, restriction profile analysis and DNA-DNA hybridisation. The remaining isolates studied produced either the broad-spectrum beta-lactamase plus the ubiquitous AmpC beta-lactamase (13 strains), or the AmpC beta-lactamase only (10 strains).

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Cefotaxime / metabolism*
  • Cephalosporins / metabolism*
  • Hydrolysis
  • Microbial Sensitivity Tests
  • Morganella morganii / drug effects
  • Morganella morganii / enzymology*
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • beta-Lactamases
  • Cefotaxime